Combined radio-chemotherapy
Showing 1 - 25 of >10,000
Rectal Tumors Trial in Belgium (Atezolizumab, 5-FU based radio-chemo)
Recruiting
- Rectal Neoplasms
- Atezolizumab
- 5-FU based radio-chemotherapy
-
Charleroi, Hainaut, Belgium
- +4 more
Dec 14, 2022
Esophageal Squamous Cell Carcinoma Trial in Beijing (Durvalumab, Carboplatin, Paclitaxel)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Durvalumab
- +3 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Mar 12, 2022
Esophageal Cancer Trial (Adjuvant Immunoradiotherapy (ARM1) and Adjuvant Immunotherapy (ARM1B), Adjuvant chemoradiotherapy)
Not yet recruiting
- Esophageal Cancer
- Adjuvant Immunoradiotherapy (ARM1) and Adjuvant Immunotherapy (ARM1B)
- Adjuvant chemoradiotherapy
- (no location specified)
Dec 19, 2022
Colon Cancer, Liver Metastasis Colon Cancer, Rectal Cancer Trial in Ramat Gan (Hepatopulmonary radio-sterilization)
Not yet recruiting
- Colon Cancer
- +2 more
- Hepatopulmonary radio-sterilization
-
Ramat Gan, IsraelSheba Medical Center
Sep 21, 2023
DLCS for Predicting Neoadjuvant Chemotherapy Response
Recruiting
- Gastric Cancer
- +4 more
- develop and visualized a radio-clinical signatures from pretreatment oversampled CT images
-
Hangzhou, Zhejiang, ChinaCancer Hospital of the University of Chinese Academy of Sciences
Nov 8, 2022
Extensive Small Cell Lung Cancer Trial in Jinan (Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy)
Recruiting
- Extensive Small Cell Lung Cancer
- Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy
-
Jinan, Shan Dong, ChinaThe First Affiliated Hospital of Shandong First Medical Universi
Nov 6, 2023
Urinary Bladder Cancer Trial in München, Ulm, Würzburg (drug, radiation, procedure)
Active, not recruiting
- Urinary Bladder Cancer
- Nivolumab
- +2 more
-
München, Germany
- +2 more
Oct 19, 2022
Gastric Cancer Trial in Xi'an (dietary supplement, biological, drug)
Recruiting
- Gastric Cancer
- Taurine
- +4 more
-
Xi'an, Shaanxi, ChinaTang-Du Hospital
Nov 2, 2023
Osteosarcoma Trial (Surufatinib plus chemo, Chemotherapy)
Not yet recruiting
- Osteosarcoma
- Surufatinib plus chemotherapy
- Chemotherapy
- (no location specified)
Jun 29, 2023
Advanced Colorectal Cancer Trial in Hangzhou (Fruquintinib Combined With Chemotherapy)
Not yet recruiting
- Advanced Colorectal Cancer
- Fruquintinib Combined With Chemotherapy
-
Hangzhou, Zhejing, ChinaZhejiang Cancer Institute & Hospital
Jun 29, 2023
Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)
Not yet recruiting
- Breast Cancer
- Triple Negative Breast Cancer
- Antivascular therapy
- Chemotherapy
- (no location specified)
Jun 11, 2023
Nasopharyngeal Carcinoma Trial in Fuzhou (without concurrent cisplatin chemo, with concurrent cisplatin chemo)
Not yet recruiting
- Nasopharyngeal Carcinoma
- without concurrent cisplatin chemotherapy
- with concurrent cisplatin chemotherapy
-
Fuzhou, Fujian, ChinaDepartment of radiation oncology, Fujian cancer hospital
Oct 18, 2023
Advanced Mucosal Melanoma Trial (Envafolimab combined with recombinant human endostatin and first-line chemo)
Not yet recruiting
- Advanced Mucosal Melanoma
- Envafolimab combined with recombinant human endostatin and first-line chemotherapy
- (no location specified)
Sep 15, 2023
Gastric Cancer Trial in Xi'an (Penpulimab combined with Anlotinib Hydrochloride Capsules and chemo;Cadonilimab combined with
Not yet recruiting
- Gastric Cancer
- Penpulimab combined with Anlotinib Hydrochloride Capsules and chemotherapy;Cadonilimab combined with Anlotinib Hydrochloride Capsules and chemotherapy
-
Xi'an, Shaanxi, ChinaThe First Affiliated Hospital of Air Force Military Medical Univ
Mar 23, 2023
Uterine Cervical Tumors, Chemoradiotherapy, Adjuvant Chemo Trial in Liuzhou (paclitaxel combined with platinum)
Recruiting
- Uterine Cervical Neoplasms
- +2 more
- paclitaxel combined with platinum
-
Liuzhou, Guangxi, Chinathe Fourth Affiliated Hospital of Guangxi Medical University
Feb 16, 2023
Tislelizumab Combined With Chemotherapy in First-line Treatment
Active, not recruiting
- Tislelizumab
- +3 more
-
Beijing, ChinaCancer Institute and Hospital, Chinese Academy of Medical Scienc
Sep 6, 2023
Gastric Cancer Trial in Shanghai (sintilimab+metronomic PLOF)
Recruiting
- Gastric Cancer
- sintilimab+metronomic PLOF
-
Shanghai, ChinaHuashan Hospital, Fudan University
Sep 22, 2023
Pancreatic Ductal Adenocarcinoma Trial (Thermal Ablation, Chemotherapy)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- Thermal Ablation
- Chemotherapy
- (no location specified)
Nov 9, 2022
Gastric Cancer Trial in Xi'an (dietary supplement, biological, drug)
Recruiting
- Gastric Cancer
- Taurine
- +3 more
-
Xi'an, Shaanxi, ChinaTang-Du Hospital
Nov 7, 2023
Advanced Lung Squamous Cell Carcinoma Trial in Chengdu (low-dose radiation therapy and stereotactic body radiation therapy,
Not yet recruiting
- Advanced Lung Squamous Cell Carcinoma
- low-dose radiation therapy and stereotactic body radiation therapy
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Nov 13, 2023
Urinary Incontinence Trial in Bluffton, W. Lake Hills (FormaV and VTone)
Completed
- Urinary Incontinence
- FormaV and VTone
-
Bluffton, South Carolina
- +1 more
Aug 9, 2022
Nausea With Vomiting Chemo-Induced Trial in Wuhan (Ondansetron every 3 weeks, Aprepitant, Dexamethasone)
Not yet recruiting
- Nausea With Vomiting Chemotherapy-Induced
- Ondansetron every 3 weeks
- +3 more
-
Wuhan, Hubei, ChinaHubei Cancer Hospital
Oct 8, 2023
Acupuncture on Acute Dysphagia in Patients Treated With
Recruiting
- Head and Neck Squamous Cell Carcinoma
-
Florence, Italy
- +1 more
Nov 6, 2022
NSCLC Trial (Tirelizumab;Chemotherapy monotherapy)
Not yet recruiting
- Non-small Cell Lung Cancer
- Tirelizumab；Chemotherapy monotherapy
- (no location specified)
Jul 27, 2023